Murphy Olwen C, Hedjoudje Abderrahmane, Salazar-Camelo Andrea, Pardo Carlos A, Gailloud Philippe
Johns Hopkins Myelitis and Myelopathy Center, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Division of Interventional Neuroradiology, Johns Hopkins Hospital, Baltimore, MD, USA.
J Neurol Sci. 2020 Jun 15;413:116863. doi: 10.1016/j.jns.2020.116863. Epub 2020 Apr 28.
To describe the clinical characteristics, delay to diagnosis and post-intervention outcomes of patients with low-flow spinal arteriovenous fistulas (SAVFs).
In this retrospective observational study, we reviewed all patients with low-flow SAVFs angiographically diagnosed at our institution between 2008 and 2018. Pre- and post-intervention disability levels were recorded using the modified Aminoff and Logue scale (mALS).
One-hundred and five patients were included. Median age was 62 years and 79% were male. Most patients (56%) presented to neurologists and 41% were misdiagnosed with myelitis. Patients underwent unnecessary treatment with corticosteroids (44%), other immunosuppressive therapies (8%) and spinal surgery (10%). Inappropriate corticosteroid treatment led to a precipitous clinical decline in 30% of patients exposed. Only 21% percent of patients were correctly diagnosed after initial evaluation; the median delay to diagnosis in the rest of the cohort was of 12 months (IQR 7 to 24 months). Longer delays to diagnosis were associated with higher levels of disability (p = .002). Treatment of SAVF was endovascular in 64% and surgical in 26%; 13% of patients required further intervention due to incomplete initial treatment or fistula recurrence. Greater than 6 months after intervention, disability scores were improved in 52% and stable in 43% of patients. In individual patients, pre- and post-intervention disability scores were strongly correlated (p < .001).
Low-flow SAVFs are associated with substantial disability and are frequently misdiagnosed. Timely diagnosis of SAVF needs to improve, as endovascular or surgical treatment results in stabilization or improvement of disability in the vast majority of patients.
描述低流量脊髓动静脉瘘(SAVF)患者的临床特征、诊断延迟情况及干预后的结局。
在这项回顾性观察研究中,我们回顾了2008年至2018年间在本机构经血管造影诊断为低流量SAVF的所有患者。采用改良的阿明诺夫和洛格量表(mALS)记录干预前后的残疾水平。
共纳入105例患者。中位年龄为62岁,79%为男性。大多数患者(56%)就诊于神经科医生,41%被误诊为脊髓炎。患者接受了不必要的皮质类固醇治疗(44%)、其他免疫抑制治疗(8%)和脊柱手术(10%)。不适当的皮质类固醇治疗导致30%接受治疗的患者临床病情急剧恶化。初次评估后仅21%的患者得到正确诊断;其余队列中诊断延迟的中位时间为12个月(四分位间距7至24个月)。诊断延迟时间越长,残疾程度越高(p = 0.002)。64%的SAVF患者接受了血管内治疗,26%接受了手术治疗;13%的患者因初始治疗不完全或瘘复发需要进一步干预。干预后6个月以上,52%的患者残疾评分改善,43%的患者残疾评分稳定。在个体患者中,干预前后的残疾评分高度相关(p < 0.001)。
低流量SAVF与严重残疾相关,且经常被误诊。需要改善SAVF的及时诊断,因为血管内或手术治疗可使绝大多数患者的残疾状况稳定或改善。